2023: A Year of Milestones for Powerful Medical
Reflecting on 2023, it was a year marked by groundbreaking achievements and significant growth. A highlight was the launch of the first certified AI platform for ECG interpretation, emphasizing our innovation in cardiovascular care.
European Heart Journal: Clinical Validation Study of the PMcardio OMI AI Model
Proudly announcing the international clinical validation study of PMcardio’s ‘Queen of Hearts’ OMI AI Model in the European Heart Journal – Digital Health, showcasing AI’s role in enhancing OMI diagnosis.
SME Europe Award: In The Heart of Innovation
Martin & Robert Herman, the founders of Powerful Medical, were honored with the prestigious SME Europe Award. This recognition underscores their commitment to entrepreneurial excellence and innovative contributions to cardiovascular medicine.
PMcardio Is the World’s First Certified AI-Powered Medical Device to Detect Acute Coronary Occlusion From the ECG
Introducing PMcardio’s Queen of Hearts: a breakthrough AI algorithm redefining heart attack treatment by detecting Acute Occlusion Myocardial Infarction (OMI).
Summary: PMcardio at ESC Congress 2023
We’re buzzing with excitement following our exhilarating experience at this year’s ESC Congress in Amsterdam. Here’s a recap of the major developments.
ACS Guidelines 2023: New ESC Update
The world’s largest cardiology congress hosted by the European Society of Cardiology (ESC) recently concluded in Amsterdam, bringing exciting news regarding the occlusion myocardial infarction (OMI) paradigm.
Dr. Fakhar Khan, Distinguished Consultant Cardiologist, Joins UK Clinical Board for PMcardio
We are thrilled to announce the latest addition to our UK Clinical Board, Dr. Fakhar Khan, an award-winning Consultant Cardiologist with a profound understanding of the unique demands of the UK’s healthcare landscape.
PMcardio Digitize: Introducing The ECG Digitization Platform Available Worldwide
If you’ve been actively following the latest in cardiology on social media, publications, or presentations, chances are you’ve come across the standout blue grid on ECGs. This signature feature is not just aesthetically captivating but also functionally transformative.
PMcardio Exhibits at ESC Congress 2023 in Amsterdam
We are excited to announce that PMcardio will participate in the prestigious ESC Congress 2023 in Amsterdam, a leading global event in cardiology. This presents a remarkable opportunity to showcase our groundbreaking research advances to the heart-health community.
Pioneering the Future of Cardiology – PMcardio Joins Forces with Cardiovascular Research Center Aalst in an AI-Driven R&D Partnership
PMcardio, a market leader in AI-powered cardiovascular diagnostics, is thrilled to announce a research and development partnership with the Cardiovascular Research Center Aalst.
